Hope Life International (HLI) established Palliative care in the Gambia as far back in 2004/2005 to care for terminate ill, the children and older people. It was established out of the concerned to provide care, pain relief and comfort measures for terminally ill patients so their death is unnecessarily painful and undignified.
We conducted first ever training in palliative care In 2009/2010, with German partner for doctors, nurses, social workers and other health care professional. The total of 45 and 53 health care professionals were trained respectively.
Approaches:
Our Work
Everything Hope Life International does is focused on one goal: improving the health and standard of life, especially the most vulnerable.
Hope Life is committed to helping vulnerable enjoy life in all its fullness. Our work with families, communities and local partners strives to improve the well-being of vulnerable people, in the most important aspects of their lives. Our efforts address basic needs, but also go beyond those to include the spiritual, psychological and relational aspects of thriving in a vibrant and empowered community.
Hope Life works in three countries, including urban and rural areas, to bring help and hope to the world’s most vulnerable. We employ local staff in order to develop local partnerships that strengthen communities and empower people.
Hope Life designed programmes to address people’s urgent needs and to ensure that people’s well-being is sustained for the long term. We work to empower communities, families and children to tackle the root causes of poverty and build a better future together.
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close